| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q36619329 | Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q57265567 | Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q47556967 | FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q35037312 | Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2 |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q50109358 | Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations? |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q28652056 | Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers |
| Q47755879 | Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine |
| Q34622507 | The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array |
| Q33763777 | Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model |
Search more.